Publications by authors named "Beatriz Collado"

Claim this Profile
D
Description of Macrophage-Like Cells in Active Ocular Toxoplasmosis.
Ester Carreño, Inés Hernanz, Beatriz Collado, Francesco Pichi

Ocul Immunol Inflamm· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells.
Ana Valdehita, María J Carmena, Beatriz Collado, Juan C Prieto, Ana M Bajo

Regul Pept· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model.
Beatriz Collado, María J Carmena, Celia Clemente, Juan C Prieto, Ana M Bajo

Peptides· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression.
Ana B Fernández-Martínez, Beatriz Collado, Ana M Bajo, Manuel Sánchez-Chapado, Juan C Prieto

Mol Cell Endocrinol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells.
Beatriz Collado, Manuel Sánchez-Chapado, Juan C Prieto, María J Carmena

Mol Cell Endocrinol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analog.
Beatriz Collado, María J Carmena, Manuel Sánchez-Chapado, Antonio Ruíz-Villaespesa, Ana M Bajo

Int J Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation.
Beatriz Collado, María G Sánchez, Inés Díaz-Laviada, Juan C Prieto, María J Carmena

Biochim Biophys Acta· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
M Olga García-Fernández, Beatriz Collado, Guillermo Bodega, Joaquin Cortés, Antonio Ruíz-Villaespesa

Gynecol Endocrinol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
Maria G Sanchez, Ana M Sanchez, Beatriz Collado, Sophie Malagarie-Cazenave, Nuria Olea

Eur J Pharmacol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K.
Irene Gutiérrez-Cañas, María G Juarranz, Beatriz Collado, Nieves Rodríguez-Henche, Antonio Chiloeches

Prostate· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells.
Beatriz Collado, Irene Gutiérrez-Cañas, Nieves Rodríguez-Henche, Juan C Prieto, María J Carmena

Regul Pept· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luteinizing hormone-releasing hormone antagonist Cetrorelix regulates the expression of Galphas and Galphai protein subunits and adenylate cyclase activity in rat ovary, breast and pituitary.
Beatriz Collado, María J Carmena, Joaquín Cortés, Andrew V Schally, Juan C Prieto

Int J Oncol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis